Physician profile
Linle Hou
NPI 1720516339
$3,336.56
in general payments reported to CMS, 2019-2025
12 companies · $292 in 2025
The $292 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $165 · 2023: $1,130 · 2024: $1,749 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,012 · Education: $73.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,011.62 |
| Education | $73.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $747.73 | 2023-2024 | Symplicity G3, Onyx Frontier, Acist Rxi System |
| Abiomed | $560.77 | 2024 | Impella |
| Zoll Circulation INC | $261.34 | 2024 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Boston Scientific Corporation | $260.81 | 2024 | Avvigo Guidance System |
| Genzyme Corporation | $252.11 | 2024-2025 | |
| Inari Medical, INC. | $247.52 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $188.64 | 2023-2024 | Brilinta |
| Amgen INC. | $165.00 | 2025 | |
| Abbott Laboratories | $160.45 | 2024 | Optis |
| Shockwave Medical, INC | $150.62 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $64.63 | 2023 | Orsiro Mission |
| Chiesi USA, INC. | $25.88 | 2024 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linle Hou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.